Loading…
Mercury Laboratories (BSE 538964)₹734.30−2.09%Pharmaceuticals
Mercury Laboratories is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 21.2 against a peer median of 17.1, and ROCE of 12.1% against a peer median of 10.8%, and latest-quarter sales growth of −12.0% against a peer median of 41.1%. By market cap it is #4 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Drugs | 96 | 44.3 | 5.5 | 2.6 | 0.28 | 0.0 | 79 | 1 | 53.9 | 900.0 | vs BSE 538964 |
| Cian Healthcare | 94 | — | −16.1 | −49.2 | 3.38 | 0.0 | 28 | −23 | 41.6 | — | vs BSE 538964 |
| Vaishali Pharma | 91 | 23.4 | 7.9 | 6.0 | 0.28 | 0.0 | 109 | 4 | — | — | vs BSE 538964 |
| Mercury Laboratories | 88 | 21.2 | 12.1 | 9.1 | 0.14 | 0.5 | 76 | 5 | −12.0 | −69.8 | — |
| Amwill Health Care | 87 | 7.6 | 21.1 | 15.4 | 0.00 | 1.2 | 43 | 11 | 41.1 | 100.0 | vs BSE 538964 |
| Jfl Life Sciences | 85 | 13.0 | 18.0 | 15.0 | 0.47 | 0.0 | 131 | 6 | −4.2 | 48.6 | vs BSE 538964 |
| Denis Chem Lab | 83 | 10.0 | 14.0 | 9.6 | 0.05 | 2.5 | 182 | 8 | 13.1 | −43.1 | vs BSE 538964 |
| Vilin Bio Med | 83 | 43.3 | 10.8 | 7.5 | 0.01 | 0.0 | 42 | 2 | 215.6 | 1,866.7 | vs BSE 538964 |
| Rekvina Labs | 81 | — | −333.3 | — | — | 0.0 | 1 | −0 | — | — | vs BSE 538964 |
| Samrat Pharmachem | 80 | — | −3.0 | −4.8 | 0.16 | 0.4 | 289 | −3 | 0.7 | — | vs BSE 538964 |
| Shelter Pharma | 76 | 8.3 | 20.4 | 15.1 | 0.01 | 0.8 | 73 | 9 | 49.8 | 22.2 | vs BSE 538964 |
| Peer median | 85 | 17.1 | 10.8 | 8.3 | 0.15 | 0.0 | 76 | 4 | 41.1 | 48.6 |
Listed companies closest to Mercury Laboratories in Pharmaceuticals include Concord Drugs, Cian Healthcare, Vaishali Pharma, Amwill Health Care, Jfl Life Sciences, Denis Chem Lab, Vilin Bio Med, Rekvina Labs.
Concord Drugs, with a market cap of ₹95.99 Cr.
Mercury Laboratories trades at a P/E of 21.2; the median of its peer set is 17.1. A P/E above or below the median is a description, not a judgement on value.
Mercury Laboratories' return on capital employed is 12.1%, above the peer median of 10.8%.